Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05085704

Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla or 3 Tesla.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The goal is to establish a protocol to 13C-label (from 13C-glucose) several physiological molecules: glucose, lactate, pyruvate and derived compounds. All of these molecules can undergo oxidation in the citric acid cycle. The intent is to study the 13C labeling pattern of these molecules in control and G1D subjects to determine if downstream products (such as 13C bicarbonate or 13C glutamate) due to oxidation in the mitochondria can be detected in brain or in blood by NMR analysis. While inside the instrument, the subjects may also undergo a 7T MR or 3T MR exam to correlate spectroscopy with brain structure.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects will be adolescents or adults, age 16-80 years in good general health (evidenced by normal vital signs and no acute signs or symptoms of illness) or with previously (not for this study) documented G1D (genetically confirmed).
  • Ages 16 to 80
  • Persons with dental fillings, dental crowns, and short (max.4 cm) dental retainer wires can be included.

Exclusion criteria

  • People or patients with uncontrolled seizure disorder, defined as grand mal (not absence) seizure in the preceding 3 months.
  • Pregnant females will be excluded. A serum or urine pregnancy test will be administered to all females of child bearing potential within 24 hours of administration of the tracer and MRI scan. The pregnancy test will be communicated in person by the study PI. Positive results in subjects 17 years old or younger will be disclosed to parent/guardian only.
  • Subjects with typical implanted orthopedic metal in bone may be considered for inclusion in a 7T scan providing the implant is not within the volume of the radio frequency coil. The PI and the AIRC Medical Director will discuss each case and determine eligibility.
  • Persons with ICD, pacemakers, neurostimulators and other such devices will be excluded.
  • Persons with claustrophobia are excluded.
  • Persons with questionable ferrous implants, bullets, BB's, and shrapnel will be excluded.
  • Subjects who are not fluent in English will be excluded because immediate cooperation and the ability to respond to instructions from the investigators are necessary.
  • People following a ketogenic diet

Treatment and study plan

Magnetic Resonance Imaging

Device

Medical imaging technique used in radiology to form pictures of the anatomy.

Other names: MRI

Primary outcomes

  1. Select metabolite abundance measured at 7Tfield strength

    Time frame: Day 1, immediately after 13 C labeled isotope infusion

    Relative spectral amplitude at equilibrium time point (equilibrium will be defined from the spectra) of the lactate, glucose and bicarbonate spectral peaks arising from infused 13C glucose as measured by magnetic resonance spectroscopy (non contrast brain MRS 7T)

  2. Select metabolite abundance measured at 3T field strength

    Time frame: Day 1, immediately after 13 C labeled isotope infusion

    Relative spectral amplitude at equilibrium time point (equilibrium will be defined from the spectra) of the lactate, glucose and bicarbonate spectral peaks arising from infused 13C glucose as measured by magnetic resonance spectroscopy (non contrast brain MRS 3T)

Study contacts

Contact information is provided by the study sponsor or research team.

Juan M Pascual, M.D.

CONTACT

[email protected]

212 746 3278

Rocio Moron Ares, B.S.

CONTACT

[email protected]

212 746 3278

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

Registry information

Important dates

Study start
2022
Primary completion
2029
Study completion
2029
First posted
Oct 20, 2021
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.